Trials / Recruiting
RecruitingNCT03962920
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Zealand University Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tigecycline 50 MG | Local instillation of drug directly to the tumour tissue |
| OTHER | Placebo | Local instillation of sterile water directly to the tumour tissue |
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2025-05-01
- Completion
- 2027-05-01
- First posted
- 2019-05-24
- Last updated
- 2024-01-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03962920. Inclusion in this directory is not an endorsement.